Heparin bibliography


Top  Previous  Next
1.Salzman EW, et al. Management of heparin therapy; a controlled prospective trial. N Engl J Med 1975; 292;1046-50.
2.Glazier RL, Crowell EB. Randomized prospective trial of continuous versus intermittent heparin therapy. JAMA 1976; 12; 1365-67.
3.Chenella FC, et al. Improved method for estimating initial heparin infusion rates. Am J Hosp Pharm 1979; 36;782-84.
4.Greenlaw CW, Henrietta GC, Stolley SN. Standardized heparin dosage schedule using pharmakokinetic principles. Am J Hosp Pharm 1979; 36;920-23.
5.Wilson JR, Lampman J. Heparin therapy: a randomized prospective study. Am Heart J 1979;155-8.
6.Estes, JW. Clinical Pharmacokinetics of Heparin. Clin Pharm 1980 5:204-220.
7.Wilson JE, Bynum LJ, Parkey RW, Heparin therapy in venous thromboembolism; JAMA 1981; 70; 808-16.
8.Self TH, et al. Concurrent initiation of heparin and warfarin therapy. Am Heart J. 1981; 102;470-71.
9.Hattersley PG, et al. Adjusting heparin infusion rates from the initial response to activated coagulation time. DICP 1983;17:632-634.
10.Saya Frank, et al. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm 1985; 42:1965-1969.
11.Carter BL. LA. Therapy of acute thromboembolism with heparin and warfarin. Clin Pharm 1991; 10; 503-15.
12.Macleod CM, et al. Comparison of two methods of continuous intravenous heparin therapy. Hosp Pharm 1985; 20;649-54.
13.Hull RD, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. NEJM 1986;18:1109-14.
14.Cipolle RJ, Rodvold KA. "Heparin", in Evans W, Schentag J, Jusko J (eds): Applied Pharmacokinetics. San Francisco. Applied Therapeutics, 1986; pp 908-943.
15.Rivey MP, Peterson JP. Pharmacy-managed, weight-based heparin protocol. AJHP 1993; 50:pp 279-84.
16.Brill-Edwards P, et al. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993; 119:104-109.
17.Raschke RA, et al. The weight-based heparin nomogram compared with a standard care nomogram: a randomized controlled trial  Ann Intern Med 1993; 119:874-81
18.Kershaw B, et al. Computer-assisted dosing of heparin: management with a pharmacy-based anticoagulation service.  Arch Intern Med 1994;154:10005-1011.
19.Campbell NR, et al.  Aging and heparin-related bleeding.  Arch Intern Med 1996; 156:857-60.
20.Schlicht JR, et al. Reevaluation of a weight-based heparin dosing nomogram: is institution specific modification necessary? Ann Pharmacother 1997; 31:1454-9.
21.White RH, et al. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on stead-state intravenous heparin requirements.  Arch Intern Med 1997;157:2468-2472.
22.Volles DF, et al. Establishing an institution-specific therapeutic range for heparin.  AJHP 1998;55:2002-6.
23.Braunwald E, et al.  Diagnosing and managing unstable angina, Quick reference quide for clinicians.  US Dept of HHS, PHS, AHCPR, NHLBI. 1994, pp 6-7.


See also:


Monitoring parameters


Pharmacokinetic formulas


. ©Copyright 1984 - 2018, by RxKinetics. All rights reserved.